المؤلفون: Tai WC; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan; Chang Gung University College of Medicine, Taiwan., Wu IT; Division of Gastroenterology, Department of Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan., Wang HM; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan., Huang PY; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan., Yao CC; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan., Wu CK; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan; Chang Gung University College of Medicine, Taiwan., Yang SC; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan., Liang CM; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan; Chang Gung University College of Medicine, Taiwan. Electronic address: gimy54861439@gmail.com., Hsu PI; Division of Gastroenterology, Department of Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan., Chuah SK; Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan; Chang Gung University College of Medicine, Taiwan.

المصدر: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2024 Aug; Vol. 57 (4), pp. 601-608. Date of Electronic Publication: 2024 Mar 04.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: published by Elsevier for the Taiwan Society of Microbiology Country of Publication: England NLM ID: 100956211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1995-9133 (Electronic) Linking ISSN: 16841182 NLM ISO Abbreviation: J Microbiol Immunol Infect Subsets: MEDLINE

مواضيع طبية MeSH: Esomeprazole*/therapeutic use , Esomeprazole*/administration & dosage , Helicobacter Infections*/drug therapy , Rabeprazole*/therapeutic use , Rabeprazole*/administration & dosage , Helicobacter pylori*/drug effects , Proton Pump Inhibitors*/therapeutic use , Proton Pump Inhibitors*/administration & dosage , Amoxicillin*/therapeutic use , Amoxicillin*/administration & dosage , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Drug Therapy, Combination*, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Taiwan ; Treatment Outcome ; Aged ; Adult

المؤلفون: Xiao X; Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu, Sichuan, China xxuenk@gmail.com xiaoxue@wchscu.cn mouse-577@163.com.; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Zhang X; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Chengdu, Sichuan, China.; Department of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Wang J; Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Liu Y; Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Yan H; Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Xing X; Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Chengdu, Sichuan, China., Yang J; Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu, Sichuan, China xxuenk@gmail.com xiaoxue@wchscu.cn mouse-577@163.com.; Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

المصدر: Gut [Gut] 2024 Jun 06; Vol. 73 (7), pp. 1098-1109. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

مواضيع طبية MeSH: Esomeprazole*/pharmacology , Feces*/microbiology , Gastrointestinal Microbiome*/drug effects , Proton Pump Inhibitors*/pharmacology , Saliva*/microbiology, Adult ; Animals ; Female ; Humans ; Male ; Mice ; Young Adult ; Bacterial Translocation/drug effects ; Chlorhexidine/pharmacology ; Healthy Volunteers ; Hydrogen-Ion Concentration ; Mouth/microbiology ; Mouthwashes/pharmacology ; Prospective Studies ; RNA, Ribosomal, 16S ; Streptococcus anginosus/drug effects ; Streptococcus anginosus/isolation & purification

المؤلفون: Sundra T; Avon Ridge Equine Veterinary Services, Brigadoon, Western Australia, Australia., Gough S; Hunter Equine Centre, Scone, New South Wales, Australia., Rossi G; School of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia, Australia., Kelty E; School of Population and Global Health, The University of Western Australia, Crawley, Western Australia, Australia., Rendle D; EMT Consulting, Devon, UK.

المصدر: Equine veterinary journal [Equine Vet J] 2024 Sep; Vol. 56 (5), pp. 952-958. Date of Electronic Publication: 2023 Sep 07.

نوع المنشور: Journal Article; Randomized Controlled Trial, Veterinary; Clinical Trial, Veterinary

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0173320 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-3306 (Electronic) Linking ISSN: 04251644 NLM ISO Abbreviation: Equine Vet J Subsets: MEDLINE

مواضيع طبية MeSH: Esomeprazole*/administration & dosage , Esomeprazole*/therapeutic use , Esomeprazole*/pharmacology , Omeprazole*/administration & dosage , Omeprazole*/therapeutic use , Horse Diseases*/drug therapy , Anti-Ulcer Agents*/administration & dosage , Anti-Ulcer Agents*/therapeutic use , Anti-Ulcer Agents*/pharmacology, Animals ; Horses ; Male ; Administration, Oral ; Stomach Diseases/veterinary ; Stomach Diseases/drug therapy ; Female

المؤلفون: Xu X; Institute of Enzyme Catalysis and Synthetic Biotechnology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 360105, China., Meng Y; Institute of Enzyme Catalysis and Synthetic Biotechnology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 360105, China., Su B; Institute of Enzyme Catalysis and Synthetic Biotechnology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 360105, China. Electronic address: subingmei@fzu.edu.cn., Lin J; Institute of Enzyme Catalysis and Synthetic Biotechnology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 360105, China. Electronic address: ljuan@fzu.edu.cn.

المصدر: Enzyme and microbial technology [Enzyme Microb Technol] 2024 Sep; Vol. 179, pp. 110469. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8003761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0909 (Electronic) Linking ISSN: 01410229 NLM ISO Abbreviation: Enzyme Microb Technol Subsets: MEDLINE

مواضيع طبية MeSH: Esomeprazole*/metabolism , Biocatalysis* , Escherichia coli*/genetics , Escherichia coli*/metabolism , Burkholderia*/genetics , Burkholderia*/enzymology , Burkholderia*/metabolism, Coenzymes/metabolism ; Biosynthetic Pathways ; Metabolic Engineering ; Formate Dehydrogenases/metabolism ; Formate Dehydrogenases/genetics ; CRISPR-Cas Systems ; Mixed Function Oxygenases/metabolism ; Mixed Function Oxygenases/genetics

المؤلفون: Valizadeh Toosi SM; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Feyzi S; Medicine faculty, Mazandaran University of Medical Sciences, Sari, Iran., Kazemi A; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

المصدر: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi [Korean J Gastroenterol] 2024 Apr 25; Vol. 83 (4), pp. 150-156.

نوع المنشور: Journal Article; Randomized Controlled Trial; Comparative Study

بيانات الدورية: Publisher: Korean Society of Gastroenterology Country of Publication: Korea (South) NLM ID: 101189416 Publication Model: Print Cited Medium: Internet ISSN: 2233-6869 (Electronic) Linking ISSN: 15989992 NLM ISO Abbreviation: Korean J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin*/therapeutic use , Anti-Bacterial Agents*/therapeutic use , Clarithromycin*/therapeutic use , Clarithromycin*/administration & dosage , Drug Therapy, Combination* , Esomeprazole*/therapeutic use , Esomeprazole*/administration & dosage , Helicobacter Infections*/drug therapy , Helicobacter pylori*/drug effects , Metronidazole*/therapeutic use, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Drug Administration Schedule ; Pantoprazole/therapeutic use ; Proton Pump Inhibitors/therapeutic use ; Treatment Outcome

المؤلفون: Muhammad HJ; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan; Department of Clinical Pharmacy, College of Pharmacy, Karbala University, Karbala, 56001, Iraq. Electronic address: huda.j.alhasnawi@gmail.com., Shimada T; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. Electronic address: t-shimada@staff.kanazawa-u.ac.jp., Fujita A; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. Electronic address: a-ueda@staff.kanazawa-u.ac.jp., Sai Y; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. Electronic address: sai-ys@staff.kanazawa-u.ac.jp.

المصدر: Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2024 Apr; Vol. 55, pp. 100995. Date of Electronic Publication: 2024 Jan 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101164773 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-0920 (Electronic) Linking ISSN: 13474367 NLM ISO Abbreviation: Drug Metab Pharmacokinet Subsets: MEDLINE

مواضيع طبية MeSH: Proton Pump Inhibitors*/pharmacology , Esomeprazole*/pharmacology , Indazoles* , Pyrimidines* , Sulfonamides*, Rats ; Animals ; Sodium Citrate ; Solubility ; Gastric Acid ; Sodium ; Water ; Hydrogen-Ion Concentration

المؤلفون: Fang Y; Department of Gastroenterology, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Department of Clinical Research Management, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China., He X; Department of Gastroenterology, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Department of Clinical Research Management, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Clinical Trial Center, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China., Peng A; Department of Gastroenterology, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Department of Clinical Research Management, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Clinical Trial Center, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China., Yang YQ; Department of Forensic Toxicological Analysis, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Wuhou, Chengdu, P.R. China., Xiang J; Department of Gastroenterology, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Department of Clinical Research Management, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Clinical Trial Center, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Feb; Vol. 13 (2), pp. 134-139. Date of Electronic Publication: 2023 Sep 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Esomeprazole* , Aryl Hydrocarbon Hydroxylases*/genetics , Aryl Hydrocarbon Hydroxylases*/metabolism, Humans ; Cytochrome P-450 CYP2C19/genetics ; Genotype ; Polymorphism, Genetic

المؤلفون: Woodman M; General Medicine, Isle of Wight NHS Trust, Newport, UK., Curtin J; Mountbatten Hospice, Newport, UK.; Palliative Care Team, Isle of Wight NHS Trust, Newport, UK., Howard P; Mountbatten Hospice, Newport, UK paul.howard1@nhs.net.; Palliative Care Team, Isle of Wight NHS Trust, Newport, UK.

المصدر: BMJ supportive & palliative care [BMJ Support Palliat Care] 2024 Jan 08; Vol. 13 (e3), pp. e751-e753. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Letter

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101565123 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-4368 (Electronic) Linking ISSN: 2045435X NLM ISO Abbreviation: BMJ Support Palliat Care Subsets: MEDLINE

مواضيع طبية MeSH: Esomeprazole*/therapeutic use, Humans ; Infusions, Intravenous ; Infusions, Subcutaneous

المؤلفون: Tirgar Fakheri S; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Shokri-Afra H; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Graham DY; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Bari Z; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Fakheri H; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

المصدر: Helicobacter [Helicobacter] 2024 Jan-Feb; Vol. 29 (1), pp. e13061.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print Cited Medium: Internet ISSN: 1523-5378 (Electronic) Linking ISSN: 10834389 NLM ISO Abbreviation: Helicobacter Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin*/administration & dosage , Esomeprazole*/administration & dosage , Helicobacter Infections*/drug therapy , Helicobacter pylori* , Organometallic Compounds*/administration & dosage, Humans ; Anti-Bacterial Agents/administration & dosage ; Drug Therapy, Combination/adverse effects ; Iran ; Pilot Projects ; Male ; Female

المؤلفون: Neishi M; Faculty of Pharmacy, Department of Pharmacy, Shujitsu University, 1-6-1 Nishikawara, Nakaku, Okayama 703-8516, Japan., Hamano H; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama 700-8558, Japan. Electronic address: hamano.hirofumi@okayama-u.ac.jp., Niimura T; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan., Denda M; Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan., Yagi K; Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan., Miyata K; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan., Lin TJ; Department of Cell and Molecular Biology, Chang Gung University, No. 259, Wenhua 1st Rd, Guishan District, Taoyuan City, Taiwan., Higashionna T; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama 700-8558, Japan., Goda M; Department of Pharmacy, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan., Zamami Y; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama 700-8558, Japan., Ishizawa K; Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan; Department of Pharmacy, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan., Nawa H; Faculty of Pharmacy, Department of Pharmacy, Shujitsu University, 1-6-1 Nishikawara, Nakaku, Okayama 703-8516, Japan.

المصدر: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2023 Sep 15; Vol. 475, pp. 116632. Date of Electronic Publication: 2023 Jul 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0333 (Electronic) Linking ISSN: 0041008X NLM ISO Abbreviation: Toxicol Appl Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Esomeprazole*/adverse effects , Drug-Related Side Effects and Adverse Reactions*, Humans ; United States ; Omeprazole/adverse effects ; Clopidogrel ; Prasugrel Hydrochloride ; Cilostazol ; Adverse Drug Reaction Reporting Systems ; Hemorrhage ; Databases, Factual